Linshuoshuo Lv1, Xiaohui Sun1, Bin Liu1, Jie Song1, David J H Wu2, Yun Gao3, Aole Li3, Xiaoqin Hu4, Yingying Mao1, Ding Ye1. 1. Department of Epidemiology, School of Public Health, Zhejiang Chinese Medical University, Hangzhou, 310053, People's Republic of China. 2. University of Minnesota Medical School, Minneapolis, MN, 55455, USA. 3. Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, 310053, People's Republic of China. 4. Department of Epidemiology, School of Public Health, Shanxi Medical University, Taiyuan, 030001, People's Republic of China.
Abstract
Purpose: Colorectal cancer (CRC) is the third-most frequently diagnosed cancer globally. Studies have linked low serum albumin with increased risk of CRC, but the causal nature of the association remains unclear. In the present study, we explored the potential causal relationship using bidirectional Mendelian randomization (MR). Methods: Instrumental variants for albumin were obtained from a genome-wide association study (GWAS) on 102,223 Eastern Asian participants to investigate the effect of albumin on CRC. Summary statistics of CRC were obtained from a GWAS on 7,062 CRC cases and 195,745 controls of Eastern Asian ancestry. Bidirectional MR analysis was performed using inverse variance weighting (IVW) for primary analysis, supplemented with a maximum likelihood-based method, MR-PRESSO test, leave-one-out analysis, and MR-Egger regression. Stratification analyses were further performed. Results: We found that genetically predicted serum albumin per unit was associated with a lower risk of CRC (OR 0.75, 95% CI 0.59-0.95 with IVW). No evidence of pleiotropy was observed. Sex-stratified MR analysis showed that serum albumin was inversely associated with risk of CRC in men (OR 0.71, 95% CI 0.53-0.96), but not in women (OR 0.81, 95% CI 0.55-1.19) using IVW. Reverse MR analysis suggested a genetic predisposition toward CRC was not associated with serum albumin. Conclusion: Our study revealed a suggestive sex disparity in the effect of albumin, which deserves further exploration of the potential biological mechanism.
Purpose: Colorectal cancer (CRC) is the third-most frequently diagnosed cancer globally. Studies have linked low serum albumin with increased risk of CRC, but the causal nature of the association remains unclear. In the present study, we explored the potential causal relationship using bidirectional Mendelian randomization (MR). Methods: Instrumental variants for albumin were obtained from a genome-wide association study (GWAS) on 102,223 Eastern Asian participants to investigate the effect of albumin on CRC. Summary statistics of CRC were obtained from a GWAS on 7,062 CRC cases and 195,745 controls of Eastern Asian ancestry. Bidirectional MR analysis was performed using inverse variance weighting (IVW) for primary analysis, supplemented with a maximum likelihood-based method, MR-PRESSO test, leave-one-out analysis, and MR-Egger regression. Stratification analyses were further performed. Results: We found that genetically predicted serum albumin per unit was associated with a lower risk of CRC (OR 0.75, 95% CI 0.59-0.95 with IVW). No evidence of pleiotropy was observed. Sex-stratified MR analysis showed that serum albumin was inversely associated with risk of CRC in men (OR 0.71, 95% CI 0.53-0.96), but not in women (OR 0.81, 95% CI 0.55-1.19) using IVW. Reverse MR analysis suggested a genetic predisposition toward CRC was not associated with serum albumin. Conclusion: Our study revealed a suggestive sex disparity in the effect of albumin, which deserves further exploration of the potential biological mechanism.
Authors: G Grimm; H Haslacher; T Kampitsch; G Endler; C Marsik; T Schickbauer; O Wagner; B Jilma Journal: Eur J Clin Invest Date: 2009-07-23 Impact factor: 4.686
Authors: Sagrario González-Trejo; José F Carrillo; D Darlene Carmona-Herrera; Patricia Baz-Gutiérrez; Roberto Herrera-Goepfert; Gloria Núñez; Francisco J Ochoa-Carrillo; Dolores Gallardo-Rincón; Vincenzo Aiello-Crocifoglio; Luis F Oñate-Ocaña Journal: Medicine (Baltimore) Date: 2017-04 Impact factor: 1.889
Authors: James Yarmolinsky; Carolina Bonilla; Philip C Haycock; Ryan J Q Langdon; Luca A Lotta; Claudia Langenberg; Caroline L Relton; Sarah J Lewis; David M Evans; George Davey Smith; Richard M Martin Journal: J Natl Cancer Inst Date: 2018-09-01 Impact factor: 13.506
Authors: Krista Fischer; Johannes Kettunen; Peter Würtz; Toomas Haller; Aki S Havulinna; Antti J Kangas; Pasi Soininen; Tõnu Esko; Mari-Liis Tammesoo; Reedik Mägi; Steven Smit; Aarno Palotie; Samuli Ripatti; Veikko Salomaa; Mika Ala-Korpela; Markus Perola; Andres Metspalu Journal: PLoS Med Date: 2014-02-25 Impact factor: 11.069
Authors: Wei Zhou; Jonas B Nielsen; Lars G Fritsche; Rounak Dey; Maiken E Gabrielsen; Brooke N Wolford; Jonathon LeFaive; Peter VandeHaar; Sarah A Gagliano; Aliya Gifford; Lisa A Bastarache; Wei-Qi Wei; Joshua C Denny; Maoxuan Lin; Kristian Hveem; Hyun Min Kang; Goncalo R Abecasis; Cristen J Willer; Seunggeun Lee Journal: Nat Genet Date: 2018-08-13 Impact factor: 38.330